Published on in Vol 5, No 2 (2019): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12090, first published .
Evaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study

Evaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study

Evaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study

Original Paper

1Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States

2McGlinn Cancer Institute, Reading Health System, West Reading, PA, United States

3Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States

4Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, United States

Corresponding Author:

Amy Leader, MPH, Dr PH

Division of Population Science

Department of Medical Oncology

Thomas Jefferson University

834 Chestnut Street

Suite 314

Philadelphia, PA, 19107

United States

Phone: 1 215 955 7739

Email: amy.leader@jefferson.edu


Background: As of 2016, almost 16 million individuals were cancer survivors, including over 3.5 million survivors of breast cancer. Because cancer survivors are living longer and have unique health care needs, the Institute of Medicine proposed a survivor care plan as a way to alleviate the many medical, emotional, and care coordination problems of survivors.

Objective: This pilot study for breast cancer survivors was undertaken to: (1) examine self-reported changes in knowledge, confidence, and activation from before receipt to after receipt of a survivor care plan; and (2) describe survivor preferences for, and satisfaction with, a technology-based survivor care plan.

Methods: A single group pretest-posttest design was used to study breast cancer survivors in an academic cancer center and a community cancer center during their medical visit after they completed chemotherapy. The intervention was a technology-based survivor care plan. Measures were taken before, immediately after, and 1 month after receipt of the survivor care plan.

Results: A total of 38 breast cancer survivors agreed to participate in the study. Compared to baseline levels before receipt of the survivor care plan, participants reported increased knowledge both immediately after its receipt at the academic center (P<.001) and the community center (P<.001) as well as one month later at the academic center (P=.002) and the community center (P<.001). Participants also reported increased confidence immediately following receipt of the survivor care plan at the academic center (P=.63) and the community center (P=.003) and one month later at both the academic center (P=.63) and the community center (P<.001). Activation was increased from baseline to post-survivor care plan at both the academic center (P=.05) and community center (P<.001) as well as from baseline to 1-month follow-up at the academic center (P=.56) and the community center (P<.001). Overall, community center participants had lower knowledge, confidence, and activation at baseline compared with academic center participants. Overall, 22/38 (58%) participants chose the fully functional electronic survivor care plan. However, 12/23 (52%) in the community center group chose the paper version compared to 4/15 (27%) in the academic center group. Satisfaction with the format (38/38 participants) and the content (37/38 participants) of the survivor care plan was high for both groups.

Conclusions: This study provides evidence that knowledge, confidence, and activation of survivors were associated with implementation of the survivor care plan. This research agrees with previous research showing that cancer survivors found the technology-based survivor care plan to be acceptable. More research is needed to determine the optimal approach to survivor care planning to ensure that all cancer survivors can benefit from it.

JMIR Cancer 2019;5(2):e12090

doi:10.2196/12090

Keywords



As of 2016, almost 16 million individuals were cancer survivors, including over 3.5 million survivors of breast cancer [1]. Because cancer survivors are living longer and have unique health care needs, the Institute of Medicine proposed a survivor care plan to alleviate the many medical, emotional, and care coordination problems of survivors [2,3]. Implementation of the survivor care plan is resource-intensive, requiring time and personnel to create and communicate the plan to survivors and other stakeholders [4,5]. Given the many time demands on health care providers, it is imperative to document the benefits of the survivor care plan to survivors. However, several randomized controlled trials have failed to show the benefits of the survivor care plan in relieving survivor distress, improving satisfaction with care, or improving care coordination [6-8].

A small body of research has not demonstrated the efficacy of the survivor care plan (both paper and electronic documents) in influencing survivor-reported outcomes. Three randomized controlled trials of a survivor care plan paper document and in-person session showed no effect on: cancer-specific or general psychological distress, health-related quality of life, satisfaction, or continuity of care [6], cancer worries, depression, or impact of cancer [7], or the helpfulness of the materials [8]. A technology-generated survivor care plan delivered after surgery and updated during follow-up visits showed a difference in the amount of information received (in favor of the survivor care plan group) but no difference in satisfaction with the information or care [9]. The survivor care plan group also reported more symptoms, expressed more illness concerns, more emotional upset, and reported more contact with their primary care physician.

While it is possible that survivors derive limited benefit from the survivor care plan, an alternative possibility is that other patient-reported outcomes, such as knowledge or confidence, could be better indicators of efficacy. Correlational studies have shown a link between receipt of a survivor care plan and increased knowledge and confidence of survivors [9-12]. Further evidence has been provided by a small randomized trial (N=79) about survivor transition coaching compared to usual care, which showed a trend for higher self-efficacy (an indicator of confidence) in the coaching group [13]. Another small randomized trial comparing two survivor care plan interventions showed increased confidence in both groups [14]. In a single-group study, perceived knowledge increased after the survivor care plan visit [15]. This evidence suggests that knowledge and confidence should be evaluated further as outcomes by which the benefit of a survivor care plan for patients can be measured.

In the context of other chronic diseases, such as diabetes or cardiac disease management, researchers have identified the construct of patient activation, which is defined as the knowledge, skill, and confidence of an individual to manage their disease [16-19]. Based on this construct, Hibbard developed a patient activation measure to document self-efficacy regarding health behaviors, internal health locus of control, and readiness for involvement in care [20,21]. A small study of a technology-based symptom care plan for neurotoxicity during cancer treatment showed a significant improvement in activation from before to after use of the care plan [22,23], suggesting that this outcome could be relevant after cancer treatment. Two other randomized trials showed mixed results: no effect [13] and increased activation after the survivor care plan visit [14]. Because a goal of the survivor care plan is to help survivors to transition from a passive patient role to an active survivor role and become more responsible for their own health care, it is possible that this measure could more precisely document the benefit of survivor care plan delivery.

To address the resource issues associated with the survivor care plan, recent efforts have been made to use technology to automate components of the survivor care plan. These efforts reflect a broader trend to use technology as a means of increasing quality of care and patient outcomes while decreasing burden on health care professionals in both cancer care and health care overall [24-26].

Another line of research has focused on the use of technology-based survivor care plans for personalized survivor care plan delivery. Researchers evaluated a prototype of a smart phone application in a small sample of survivors and providers in a hypothetical situation [27]. Both patients and providers rated the prototype as usable, portable, and accessible. A Web-based program was designed to generate a tailored survivor care plan by incorporating input from the electronic health record and directly from patients [28]. In a sample of 25 breast cancer survivors, self-reported confidence was high before and after receiving the survivor care plan; 70% were very satisfied with it, and usability ratings were high. At least 75% of oncology and primary care providers endorsed the program. Investigators evaluated a technology-based platform with two components, a symptom care plan and a survivor care plan, and found the symptom care component to be feasible, usable, and acceptable to breast cancer patients receiving neurotoxic chemotherapy [22,23]. In contrast, a randomized study comparing two Web-based survivor care plan tools (completed by the provider versus the survivor) showed low completion rates by both groups [29], suggesting that technology alone may not solve the problem of survivor care plan implementation.

In summary, previous research provides some evidence that self-reported survivor knowledge, confidence, and activation may be sensitive to receipt of a survivor care plan, either paper or electronic. However, further research is necessary to examine survivor-reported outcomes and survivor experience associated with use of a technology-based survivor care plan. In addition to evaluating changes in survivor-reported outcomes during the implementation of a technology-based survivor care plan, this research describes preferences for and satisfaction with the technology and format in which the survivor care plan was delivered.

The objectives of this pilot study were to: (1) examine self-reported changes in knowledge, confidence, and activation from before to after receipt of an electronically generated survivor care plan by breast cancer survivors in an academic cancer clinic and a community cancer clinic; and (2) describe survivor preferences for and satisfaction with implementation of an electronic survivor care plan.


Data Collection

The Institutional Review Board approved the research and each participant provided informed consent. Eligible individuals were required to: have pathologically confirmed breast cancer, stages I-III; be over 18 years old; be completing a course of chemotherapy; and be able to understand and read English. Participants recruited from a National Cancer Institute–designated comprehensive academic cancer center and a community-based cancer center were enrolled at the follow-up medical visit after completion of chemotherapy. The study used a single-group pretest-posttest design. Participants completed surveys both before (see Multimedia Appendix 1) and after (see Multimedia Appendix 2) the medical visit and then one month later (see Multimedia Appendix 3) to document changes in knowledge, confidence, and activation as well as preference for, and satisfaction with, the technology-based survivor care plan.

The intervention consisted of a customized survivor care plan that was developed and delivered via the Carevive Survivor Care Planning system, a proprietary cloud-based system. This system uses clinical data input into a proprietary rules engine that automatically generates a draft care plan based on diagnosis, treatment regimen, current clinical practice guidelines, and nationally established quality metrics. The clinician can review, edit, and customize the plan prior to sign off and delivery to the survivor. The customized survivor care plan includes a treatment summary as well as a care plan describing recommended medical tests, appointments to schedule, and links to vetted resources and reading materials about survivor health concerns that are maintained and updated by the vendor. As a survivor’s treatment and disease history progress, providers can input additional information to the planning system and the survivor care plan will be updated accordingly. This feature of the Carevive system decreases the work required of providers in creating survivor care plans. Rather than requiring providers to continuously keep track of recommendations to survivors and update them based on treatment progression, the Carevive system allows them to simply transfer information on treatment and disease progression from the electronic medical record into the Carevive program interface, and then review and sign off on the survivor care plan that is automatically generated. Ideally, the survivor care plan document is delivered to the individual electronically (via email or encrypted flash drive), thus enabling full use of active links to information; however, the survivor care plan document can also be printed and delivered in paper form per the preference of the survivor. The most prominent difference in features between the electronic and paper versions of the survivor care plan is that the electronic version includes embedded links that allow survivors to directly and immediately access educational resources on their personal computers or mobile devices. Within the Carevive platform, data are maintained in a secure database with Health Insurance Portability and Accountability Act–compliant standards of privacy and security.

Survivor-Reported Outcomes

We evaluated knowledge and confidence with scales created by the researchers to document changes in survivor-reported knowledge of care expectations and confidence about completing the necessary tasks related to the care plan. These scales were used to distinguish knowledge or information deficits and self-efficacy or skill-related gaps. Each scale contained seven items rated on a 4-point scale from strongly disagree to strongly agree. An example of a knowledge item was: “I know which medical tests need to be done over the next year and when to get them done.” A confidence item was: “I am confident that I will get the medical tests done on time over the next year.” Within each scale, items were summed, the total score for each scale ranged from 7 to 28, and higher scores indicated higher knowledge or confidence.

We also measured self-reported survivor activation. The activation survey is a 13-item scale measuring the degree to which individuals feel prepared to actively participate in self-management [20,21]. Items are measured on a 4-point Likert scale with a range of strongly agree to strongly disagree. Total raw scores ranged from 13-52 (lowest to highest activation). Psychometric evaluation in previous research has revealed strong reliability and validity [20]. In groups with chronic illnesses, higher activation scores predicted higher likelihoods of engagement in preventive health behaviors, of seeking out health information, of performing regular self-monitoring at home, and of lower health care utilization [17,19,30]. In addition to being a measurable construct, activation can be influenced by interventions, such as delivery of a survivor care plan, that focus on providing information and resources to guide action [30,31].

Survivor Preference and Satisfaction

We examined survivor preferences for the fully functional electronic format of the survivor care plan with or without a paper document versus the paper document alone. We asked participants to rate their satisfaction with the chosen format on a 4-point scale from strongly agree to strongly disagree, as well as to rate the acceptability of the content (ie, ease of understanding, helpfulness of the information and resources, satisfaction with the experience, and recommendation to others) on a separate 4-point scale from strongly agree to strongly disagree.

Statistical Analysis

Demographic characteristics of the subjects were summarized by means and SDs or counts and percentages, as appropriate, stratifying by site (academic or community center). We assessed differences between the sites with two-tailed t tests and Fisher’s exact test.

To evaluate the changes in the survivor-reported outcomes, we fit linear mixed models using the MIXED Procedure (PROC MIXED) in SAS 9.4 (SAS Institute Inc, Cary, North Carolina). Fixed effects included site, time point, and a site by time point interaction; a random intercept was allowed for each subject. We considered several possible correlation structures to account for the repeated measures within subject, including unstructured, compound symmetry, and first-order autoregressive, with the final selection, compound symmetry, based on Akaike Information Criterion. Boxplots display the distribution of knowledge, confidence, and activation scores for the subjects at each time point and site. We also used Fisher’s exact test to evaluate the association between preferred survivor care plan format and available demographics characteristics. For all analyses, Cronbach alpha=.05.


Demographics

A total of 38 breast cancer survivors agreed to participate in the study, 15 in the academic center and 23 in the community center group (Table 1). The sample was primarily non-Hispanic white and married or partnered, and about half had at least some college education. Overall, 7/15 academic center participants (46%) and 8/23 community center participants (30%) were working at the time of the study.

Table 1. Demographic characteristics by clinical setting.
DemographicsAcademic Center (n=15)Community Center (n=23)P value
Age, mean (SD)57.6 (12.8)52.3 (12.8).22
Race, n (%)

.64

African American4 (27)3 (13)

Caucasian11 (73)19 (83)

Other0 (0)1 (4)
Ethnicity, n (%)

.14

Non-Hispanic15 (100)19 (83)

Hispanic0 (0)4 (17)
Marital Status, n (%)

.88

Single2 (13)2 (9)

Married or partnered10 (67)17 (74)

Divorced, separated, widowed3 (20)4 (17)
Education, n (%)

.08

High school, vocational/technical3 (20)11 (48)

College (Associates/Bachelors)8 (53)11 (48)

Advanced degree4 (27)1 (4)
Employment, n (%)

.76

Work full/part-time7 (47)8 (35)

Unemployed0 (0)1 (4)

Retired4 (27)8 (35)

Disabled4 (27)4 (17)

Homemaker0 (0)2 (9)

Survivor-Reported Outcomes

Participants at both sites reported significant increases in knowledge from baseline to immediately after receipt of the survivor care plan and 1 month later (Table 2). At baseline, the community center group had lower knowledge levels than the academic center group (mean difference 2.5; 95% CI 0.0-4.9; P=.05). Knowledge was similar between the sites immediately post–survivor care plan and 1 month later (Figure 1). Baseline confidence was also slightly lower in the community center compared to the academic center group (mean difference 2.0; 95% CI 0.1-4.0; P=.04) (Table 2). Confidence scores of the community center group increased from baseline to immediately and 1-month post–survivor care plan, and confidence levels of the academic center group did not significantly change (Figure 2). Like knowledge and confidence, community center participants had lower levels of activation at baseline compared to the academic center (mean difference 3.9; 95% CI 0.3-7.5; P=.04) (Table 2). The activation score improved for the community center participants at the immediate, post, and 1-month time points relative to baseline. Academic center participants saw modest improvement at the immediately post–survivor care plan time point (change=2.2; 95% CI 0.0-4.5; P=.05), but the 1-month activation scores were not significantly different from baseline (Figure 3).

Table 2. Model-estimated least squares means for knowledge, confidence, and activation over time for each setting.
CategoriesAcademic center mean (95% CI)Community center mean (95% CI)Difference mean (95% CI)P value
Knowledge




Pre-SCPa18.7 (16.8-20.7)16.3 (14.7-17.8)2.5 (0.0-4.9).05

Post-SCP22.8 (20.8-24.8)23.3 (21.7-24.9)–0.4 (–3.0 to 2.1).73

1 month post-SCP22.3 (20.3-24.3)22.1 (20.6-23.7)0.2 (–2.4 to 2.7).91

Change from pre to post4.1 (2.0-6.2)7.0 (5.3-8.7)b


P value<.001<.001

Change from pre to 1 month3.6 (1.4)5.9 (4.2-7.6)



P value.002<.001
Confidence




Pre-SCP23.6 (22.1-25.1)21.6 (20.3-22.8)2.0 (0.1-4.0).04

Post-SCP24.0 (22.4-25.5)23.3 (22.1-24.5)0.7 (–1.3 to 2.6).51

1 month post-SCP24.0 (22.4-25.6)23.7 (22.5-24.9)0.3 (–1.8 to 2.3).80

Change from pre to post0.4 (–1.1 to 1.8)1.7 (0.6-2.9)


P value.63

Change from pre to 1 month0.4 (–1.1 to 1.9)2.1 (1.0-3.3)



P value.63
Activation




Pre-SCP42.6 (39.8-45.4)38.7 (36.5-41.0)3.9 (0.3-7.5).04

Post-SCP44.8 (42.0-47.7)43.2 (40.9-45.4)1.6 (–2.0 to 5.3).37

1 month post-SCP43.3 (40.4-46.2)43.1 (40.8-45.3)0.2 (–3.5 to 3.9).91

Change from pre to post2.2 (0.0-4.5)4.4 (2.7-6.2)


P value.05<.001

Change from pre to 1 month0.7 (–1.7 to 3.1)4.3 (2.5-6.1)


P value.56<.001

aSCP: survivor care plan.

bNot applicable.

Figure 1. Knowledge levels of study participants before, immediately after, and one-month after SCP presentation. At baseline, the community center group had lower knowledge levels than the academic center group. Knowledge was similar between the sites immediately post-SCP and 1 month later. SCP: survivor care plan.
View this figure
Figure 2. Confidence level before, immediately after, and one-month after SCP presentation. Confidence at baseline was slightly lower in the community center compared to the academic center. Confidence scores of the community center group increased from baseline to immediately and one month post-SCP; confidence levels of the academic center group did not significantly change. SCP: survivor care plan.
View this figure
Figure 3. Activation levels before, immediately after, and one month after SCP presentation. Community center participants had lower levels of activation at baseline compared to the academic center. Activation score improved for community center participants at the immediate post and one-month time points relative to baseline. Academic center participants saw modest improvement at the immediately post time point, but the one-month activation scores were not significantly different from baseline. SCP: survivor care plan.
View this figure

Survivor Preference and Satisfaction

Overall, 22/38 (58%) of participants chose the fully functional electronic survivor care plan with or without a paper version (Table 3). It is noteworthy that 12 (52%) of the community center participants requested the paper version of the survivor care plan in comparison to 4 (27%) of the academic center participants. Survivor care plan format preference did not differ between sites with regard to age (P=.51), employment status (working versus not working, P=.86), or education (high school versus college, P=.83) (see Multimedia Appendix 4). All participants were satisfied with their chosen survivor care plan format, and almost all participants at both sites, regardless of chosen format, found the survivor care plan to be easy to understand, with useful information and resources. All but one participant agreed or strongly agreed that the experience was positive and that they would recommend the survivor care plan to other survivors.

Table 3. Preference for and acceptability of technology-based survivor care plan by clinical setting.
CategoriesAcademic center (n=15), n (%)Community center (n=23), n (%)P value
SCP format  .16

Flash drive3 (20)1 (4)

Paper document4 (27)12 (52)

Both flash drive and paper document8 (53)10 (43)
Format useful  .74

Agree7 (47)13 (57)

Strongly agree8 (53)10 (43)
Overall experience  .66

Negative1 (7)0 (0)

Positive3 (20)5 (22)

Very positive11 (73)18 (78)

The results of our examination of the efficacy of the survivor care plan show that participants reported positive changes in knowledge, confidence, and activation from before to after using the technology-based survivor care plan; this suggests that use of the survivor care plan could be responsible for these changes. While the positive change cannot be attributed definitively to the implementation of the survivor care plan, it suggests the need for a randomized controlled trial to test this hypothesis.

We noted that the confidence scores of the community center group increased from baseline to both subsequent time points, while the confidence levels of the academic center group did not significantly change. Community center activation scores were also improved at the immediately post–survivor care plan receipt time point as well as 1 month later, while activation scores at the academic center improved only modestly at the time point immediately post–survivor care plan receipt and at the 1-month time point were not significantly different from baseline. The differences in confidence and activation between the academic and community settings are difficult to explain.

Previous clinical trials evaluating survivor-level outcomes found no effect of survivor care plans on quality of life, mood disturbances, or satisfaction with care [6-8]. This research has identified alternative patient-reported outcomes that may more appropriately capture the variables likely to be influenced by a survivor care plan. Knowledge and confidence have both been identified in many theories as psychological variables that are likely to be involved in behavioral change [32-34]. Activation has also been identified in research on self-management of chronic diseases as an important indicator of readiness to take an active participatory role in one’s health care [17]. Thus, despite a relatively small sample size, the fact that our exploratory study found positive changes in all three of these measures after survivor care plan implementation suggests that survivors may benefit from survivor care plan use, and also invites further investigation of survivor care plan efficacy.

The second goal of this research was to examine uptake of the fully functional electronic version of the survivor care plan versus the paper document only. In this sample, 22/38 (58%) participants chose the electronic survivor care plan, either by itself or in addition to the paper survivor care plan. A total of 34/38 (89%) participants chose the paper format, either by itself or in addition to the electronic survivor care plan. However, only 4/38 (11%) participants elected to receive just the flash drive, compared to 16 (42%) who elected to receive only paper. It could be argued that technology is not fully functional until a substantial majority choose the technology-based option. A platform that functions exclusively electronically thus runs the risk of leaving behind patients who lack the skills to access it and deepening disparities that affect cancer patients and survivors.

Another feature of this study was the comparison between an academic and a community setting. Although we noted differences in survivor care plan format preference by treatment setting, the difference could not be attributed to age, education, or work status differences. However, we did not include any indicators of technological aptitude or savviness that could further explain the difference, such as frequency of interaction with an electronic interface or use of a smartphone. Regarding survivor care plan acceptability, our research agrees with past studies showing that cancer survivors have generally found technology-based survivor care plans acceptable [22,27,28]. Future research should evaluate the influence of technology literacy and aptitude on the choice of survivor care plan format in different clinical settings.

Our study sought to shed light on the potential for this novel electronic platform as a means of generating and delivering survivor care plans to breast cancer survivors. The fact that the survivor care plan examined in our study was offered in two formats strengthened our examination of survivor care plan efficacy by maximizing accessibility to participants. However, because the participants were offered the option of receiving their survivor care plan in both electronic and paper formats it limited our ability to draw conclusions regarding the electronic format, thus ultimately acting as a double-edged sword. Participants who selected both options were not queried about which of the formats they used, and their satisfaction with and perceived benefit from that format.

This pilot study had several additional limitations. First, it was not a randomized controlled trial, so the results are hypothesis-generating and not generalizable. Second, the sample size was small. A third limitation of this research was its lack of focus on clinician perceptions of this technology-based survivor care plan. A more robust evaluation of this intervention would require that all these limitations be addressed.

This research has contributed to the developing body of knowledge about the implementation of technology-based survivor care plans. The identification of patient-reported outcomes that are likely to be influenced by a survivor care plan intervention has been a barrier to success in previous research. It is possible that the outcomes measured in this research (knowledge, confidence, and activation) could be more appropriate indicators of efficacy for paper- or technology-based survivor care plans. Cancer survivors have attested to the acceptability of survivor care plans; however, challenges remain in fully implementing technology-based survivor care plans.

Acknowledgments

The authors acknowledge the contributions of Tina McKennon, CRNP, of the breast oncology team at the Sidney Kimmel Cancer Center. We also acknowledge the contributions of Crystal Rios, Barbara Miller, Aracelis Alvarez, and Patricia Weiser of Reading Health System, as well as Carrie Tompkins Stricker of Carevive Systems, Inc. This paper is dedicated to the memory of Bryan Lerner, MD, whose commitment to this project in its earliest days was emblematic of his devotion to compassionate patient care in general and humanistic oncologic care in particular.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Survey administered to study patients in person before visit with medical oncologist in which SCP was given to them.

PDF File (Adobe PDF File), 47 KB

Multimedia Appendix 2

Survey administered to study patients in person immediately after SCP was given to them by medical oncologist.

PDF File (Adobe PDF File), 50 KB

Multimedia Appendix 3

Survey administered to study patients over the phone one month after receiving SCP.

PDF File (Adobe PDF File), 46 KB

Multimedia Appendix 4

Supplemental Table 1: SCP format selection.

PDF File (Adobe PDF File), 89 KB

  1. Miller K, Siegel R, Jemal A. American Cancer Society. 2016. Cancer Treatment and Survivorship: Facts and Figures 2016-2017   URL: https://tinyurl.com/wlxcyos [accessed 2019-10-20]
  2. Stricker CT, O'Brien M. Implementing the Commission on Cancer Standards for Survivorship Care Plans. Clinical Journal of Oncology Nursing 2014 Jan 30;18(s1):15-22. [CrossRef]
  3. Maria H, Sheldon G, Ellen S, editors. From Cancer Patient To Cancer Survivor: Lost In Transition. Washington, DC: The National Academies Press; 2006.
  4. Mayer DK, Birken SA, Check DK, Chen RC. Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer 2015 Apr 01;121(7):978-996 [FREE Full text] [CrossRef] [Medline]
  5. Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 2014 Nov 11;111(10):1899-1908 [FREE Full text] [CrossRef] [Medline]
  6. Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer. JCO 2011 Dec 20;29(36):4755-4762. [CrossRef]
  7. Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 2013 Apr 31;138(3):795-806. [CrossRef] [Medline]
  8. Brothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol 2013 Jun;129(3):554-558 [FREE Full text] [CrossRef] [Medline]
  9. Nicolaije KA, Ezendam NP, Vos MC, Pijnenborg JM, Boll D, Boss EA, et al. Impact of an Automatically Generated Cancer Survivorship Care Plan on Patient-Reported Outcomes in Routine Clinical Practice: Longitudinal Outcomes of a Pragmatic, Cluster Randomized Trial. JCO 2015 Nov;33(31):3550-3559. [CrossRef]
  10. Nissen MJ, Tsai ML, Blaes AH, Swenson KK, Koering S. Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors' knowledge about their diagnosis and treatment. J Cancer Surviv 2013 Jun 17;7(2):211-218. [CrossRef] [Medline]
  11. Nissen MJ, Tsai ML, Blaes AH, Swenson KK. Breast and colorectal cancer survivors' knowledge about their diagnosis and treatment. J Cancer Surviv 2012 Mar 7;6(1):20-32. [CrossRef] [Medline]
  12. Faul LA, Shibata D, Townsend I, Jacobsen PB. Improving survivorship care for patients with colorectal cancer. Cancer Control 2010 Jan;17(1):35-43. [CrossRef] [Medline]
  13. Kvale EA, Huang CS, Meneses KM, Demark-Wahnefried W, Bae S, Azuero CB, et al. Patient-centered support in the survivorship care transition: Outcomes from the Patient-Owned Survivorship Care Plan Intervention. Cancer 2016 Oct 15;122(20):3232-3242 [FREE Full text] [CrossRef] [Medline]
  14. Mayer DK, Green M, Check DK, Gerstel A, Chen RC, Asher G, et al. Is there a role for survivorship care plans in advanced cancer? Support Care Cancer 2015 Aug 7;23(8):2225-2230. [CrossRef] [Medline]
  15. Palmer SC, Stricker CT, Panzer SL, Arvey SA, Baker KS, Casillas J, et al. Outcomes and Satisfaction After Delivery of a Breast Cancer Survivorship Care Plan: Results of a Multicenter Trial. JOP 2015 Mar;11(2):e222-e229. [CrossRef]
  16. Hibbard JH. Moving toward a more patient-centered health care delivery system. Health Aff (Millwood) 2004 Jan;Suppl Variation(Suppl2):VAR133-VAR135. [CrossRef] [Medline]
  17. Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 2012 May 30;27(5):520-526 [FREE Full text] [CrossRef] [Medline]
  18. Marshall R, Beach MC, Saha S, Mori T, Loveless MO, Hibbard JH, et al. Patient activation and improved outcomes in HIV-infected patients. J Gen Intern Med 2013 May 4;28(5):668-674 [FREE Full text] [CrossRef] [Medline]
  19. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage 2007;30(1):21-29. [CrossRef] [Medline]
  20. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res 2005 Dec;40(6 Pt 1):1918-1930 [FREE Full text] [CrossRef] [Medline]
  21. Hibbard J, Stockard J, Mahoney E, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004 Aug;39(4 Pt 1):1005-1026 [FREE Full text] [CrossRef] [Medline]
  22. Knoerl R, Dudley WN, Smith G, Bridges C, Kanzawa-Lee G, Lavoie Smith EM. Pilot Testing a Web-based System for the Assessment and Management of Chemotherapy-Induced Peripheral Neuropathy. CIN: Computers, Informatics, Nursing 2017;35(4):201-211. [CrossRef]
  23. Knoerl R, Lee D, Yang J, Bridges C, Kanzawa-Lee G, Lita Smith G, et al. Examining the Impact of a Web-based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and Management. J Cancer Educ 2018 Oct 6;33(5):1027-1035. [CrossRef] [Medline]
  24. Drewes C, Kirkovits T, Schiltz D, Schinkoethe T, Haidinger R, Goldmann-Posch U, et al. EHealth Acceptance and New Media Preferences for Therapy Assistance Among Breast Cancer Patients. JMIR Cancer 2016 Sep 14;2(2):e13 [FREE Full text] [CrossRef] [Medline]
  25. van Kasteren Y, Freyne J, Hussain MS. Total Knee Replacement and the Effect of Technology on Cocreation for Improved Outcomes and Delivery: Qualitative Multi-Stakeholder Study. J Med Internet Res 2018 Mar 20;20(3):e95 [FREE Full text] [CrossRef] [Medline]
  26. Kuijpers W, Groen WG, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. eHealth for Breast Cancer Survivors: Use, Feasibility and Impact of an Interactive Portal. JMIR Cancer 2016 May 10;2(1):e3 [FREE Full text] [CrossRef] [Medline]
  27. Baseman J, Revere D, Baldwin L. A Mobile Breast Cancer Survivorship Care App: Pilot Study. JMIR Cancer 2017 Sep 26;3(2):e14 [FREE Full text] [CrossRef] [Medline]
  28. O'Hea E, Wu J, Dietzen L, Harralson T, Boudreaux E. The Polaris Oncology Survivorship Transition (POST) System: A Patient- and Provider-Driven Cancer Survivorship Planning Program. J Oncol Navig Surviv 2016 Nov;7(10):11-24 [FREE Full text] [Medline]
  29. Smith KC, Tolbert E, Hannum SM, Radhakrishnan A, Zorn K, Blackford A, et al. Comparing Web-based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled Trial. JMIR Cancer 2016 Aug 30;2(2):e12 [FREE Full text] [CrossRef] [Medline]
  30. Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood) 2013 Mar;32(2):207-214. [CrossRef] [Medline]
  31. Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res 2007 Aug;42(4):1443-1463 [FREE Full text] [CrossRef] [Medline]
  32. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Upper Saddle River, NJ: Prentice Hall; 1985:617.
  33. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992 Apr;16(2):143-163. [CrossRef]
  34. Miller S, Diefenbach M, Krantz D, Baum A. The Cognitive-Social Health Information-Processing (C-SHIP) model: A theoretical framework for research in behavioral oncology. In: Krantz D, editor. Technology and methods in behavioral medicine. Mahwah, New Jersey: Lawrence Erlbaum; 1998:219-244.

Edited by H Wu; submitted 06.09.18; peer-reviewed by H Liu, T Felder; comments to author 07.02.19; revised version received 21.05.19; accepted 03.09.19; published 20.12.19

Copyright

©Talya Laufer, Bryan Lerner, Anett Petrich, Anna M Quinn, Leah Ernst, Alicin Roop, Janet Knoblauch, Nick C Leasure, Rebecca J Jaslow, Sarah Hegarty, Amy Leader, Andrea Barsevick. Originally published in JMIR Cancer (http://cancer.jmir.org), 20.12.2019.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.